R&F Capital Advisors’s Applied Genetic Technologies Corporation AGTC Stock Holding History

R&F Capital Advisors’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$104K	Buy	+15,138	New	+$118K	0.03%	613

Other funds holding AGTC

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

R&F Capital Advisors's AGTC Position: Q1 2017 in Review

R&F Capital Advisors opened a new position in Applied Genetic Technologies Corporation (AGTC) in Q1 2017: 15,138 shares worth $104K. The stake represents 0.03% of the portfolio and ranks #613 among its holdings.

89 funds tracked by Wall St. Rank hold AGTC as of Q1 2017.

R&F Capital Advisors held 15,138 shares of Applied Genetic Technologies Corporation worth $104K as of Q1 2017.
Applied Genetic Technologies Corporation was a new R&F Capital Advisors position in Q1 2017.
Applied Genetic Technologies Corporation made up 0.03% of R&F Capital Advisors's portfolio in Q1 2017, its #613 holding.
89 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.